Efficacy and safety of sucroferric oxyhydroxide compared with sevelamer hydrochloride in Japanese haemodialysis patients with hyperphosphataemia: A randomized, open‐label, multicentre, 12‐week phase III study [PDF]
, 2016 Fumihiko Koiwa +4 more
openalex +1 more source
Sevelamer reduces endothelial inflammatory response to advanced glycation end products [PDF]
, 2017 Paulo Cézar Gregório +8 more
openalex +1 more source
Lack of mortality benefit with sevelamer [PDF]
, 2008 Charles R. Nolan, David A. McCarron
openalex +1 more source
MP753PHARMACOECONOMIC ASSESSMENT OF PATIENTS SWITCHING FROM SUCROFERRIC OXHYDROXIDE TO SEVELAMER CARBONATE IN PATIENTS ON HEMODIALYSIS IN SEVEN EUROPE COUNTRIES [PDF]
, 2017 Mark P. Connolly +3 more
openalex +1 more source
The Outpatient Prescribing Pattern of Sevelamer in Al Seih
, 2021 Nehad J. Ahmed, Mohd Faiyaz Khan
openalex +2 more sources
The efficacy and safety of sevelamer and lanthanum versus calcium-containing and iron-based binders in treating hyperphosphatemia in patients with chronic kidney disease: a systematic review and meta-analysis [PDF]
, 2016 Steven Habbous +5 more
openalex +1 more source
Multi-Modal Treatment Of Calciphylaxis With Sodium-Thiosulfate, Cinacalcet And Sevelamer Including Long-Term Data [PDF]
, 2013 Hermann Salmhofer +9 more
openalex +1 more source
Vascular calcification: pathogenesis, epidemiology anda clinical impact [PDF]
, 2010 Several studies suggest that vascular calcifications play a main role in the cardiovascular disease, which is one of the main causes of mortality in CKD patients.
Cabezas, Iván +5 more
core
MP591COST-MINIMISATION ANALYSIS OF SUCROFERRIC OXYHYDROXIDE AND SEVELAMER CARBONATE IN PATIENTS ON DIALYSIS WITH SECONDARY HYPERPARATHYROIDISM IN THE UNITED KINGDOM [PDF]
, 2016 Joris van Stiphout +5 more
openalex +1 more source
Doença Mineral e Óssea (DMO) num Transplantado Renal [PDF]
, 2014 A 50-year-old post-menopausal recipient of a kidney allograft with bone pain, osteoporosis, persistent hypercalcaemia and elevated parathormone (PTH) levels, despite a satisfactory graft function, was treated with bisphosphonates and cinacalcet starting,
Adragão, T +14 more
core